Target intelligence / Profile preview

Paracrine and extracellular matrix environment

Molecular classification
Other
01

Overview

The paracrine and extracellular matrix (ECM) environment is a complex, multi-component system rather than a single molecular target. It consists of a structural scaffolding made of proteins like collagen, laminin, and fibronectin, interspersed with a dynamic network of secreted signaling molecules that mediate communication between adjacent cells (Source: Alberts B, et al., Molecular Biology of the Cell, 2002). This environment plays a critical role in regulating cell survival, proliferation, and differentiation by providing both mechanical cues and a reservoir for growth factors (Source: National Cancer Institute). In many diseases, particularly cancer and chronic fibrosis, the ECM is pathologically remodeled to create a 'reactive stroma' that supports tumor growth, facilitates metastasis, and acts as a physical barrier to drug delivery (Source: Joyce JA & Pollard JW, Nature Reviews Cancer, 2009). Therapeutic interventions targeting this environment often focus on specific components, such as inhibiting vascular endothelial growth factor (VEGF) to disrupt paracrine angiogenesis or using enzymes to degrade hyaluronan to improve intratumoral pressure (Source: Provenzano PP, et al., Cancer Cell, 2012).

Other names
Extracellular matrixParacrine signaling systemTumor microenvironmentStromaCellular microenvironment
02

Mechanism of action

Inhibition of secreted growth factors, enzymatic degradation of structural matrix components, or blockade of paracrine signaling pathways to disrupt disease-promoting microenvironments.

03

Biological functions

Signal transductionCell-cell communicationStructural supportCell adhesionGrowth factor sequestrationTissue homeostasis
04

Disease associations

CancerFibrosisInflammationCardiovascular diseaseWound healing disorders
05

Safety considerations

Impaired wound healingTissue perforation or ruptureSystemic toxicity from disrupting homeostatic signalingOff-target effects on healthy connective tissue
06

Interacting drugs

Bevacizumab

4 more in the full profile.

07

Biomarkers

Matrix metalloproteinases (MMPs)Collagen type I C-telopeptide (CTX)Transforming growth factor beta (TGF-beta) levelsFibronectin splice variants

Beyond the preview

Go deeper on Paracrine and extracellular matrix environment.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Paracrine and extracellular matrix environment.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call